You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › April › 24
FDA
3 months ago
It's a big shift toward supporting psychedelic-based medicines for treatment-resistant depression, PTSD and substance use disorders, the FDA said.
page 1 of 1